首页> 外文期刊>The journal of immunology >In Vivo Hydrodynamic Delivery of cDNA Encoding IL-2: Rapid, Sustained Redistribution, Activation of Mouse NK Cells, and Therapeutic Potential in the Absence of NKT Cells
【24h】

In Vivo Hydrodynamic Delivery of cDNA Encoding IL-2: Rapid, Sustained Redistribution, Activation of Mouse NK Cells, and Therapeutic Potential in the Absence of NKT Cells

机译:编码IL-2的cDNA的体内流体动力学传递:快速,持续的重新分布,小鼠NK细胞的激活和缺乏NKT细胞的治疗潜力。

获取原文
       

摘要

In the present study, we have tested the ability of hydrodynamically delivered IL-2 cDNA to modulate the number and function of murine leukocyte subsets in different organs and in mice of different genetic backgrounds, and we have evaluated effects of this mode of gene delivery on established murine tumor metastases. Hydrodynamic administration of the IL-2 gene resulted in the rapid and transient production of up to 160 ng/ml IL-2 in the serum. The appearance of IL-2 was followed by transient production of IFN-γ and a dramatic and sustained increase in NK cell numbers and NK-mediated cytolytic activity in liver and spleen leukocytes. In addition, significant increases in other lymphocyte subpopulations (e.g., NKT, T, and B cells) that are known to be responsive to IL-2 were observed following IL-2 cDNA plasmid delivery. Finally, hydrodynamic delivery of only 4 μg of the IL-2 plasmid to mice bearing established lung and liver metastases was as effective in inhibiting progression of metastases as was the administration of large amounts (100,000 IU/twice daily) of IL-2 protein. Studies performed in mice bearing metastatic renal cell tumors demonstrated that the IL-2 cDNA plasmid was an effective treatment against liver metastasis and moderately effective against lung metastasis. Collectively, these results demonstrate that hydrodynamic delivery of relatively small amounts of IL-2 cDNA provides a simple and inexpensive method to increase the numbers of NK and NKT cells, to induce the biological effects of IL-2 in vivo for use in combination with other biological agents, and for studies of its antitumor activity.
机译:在本研究中,我们测试了水动力递送的IL-2 cDNA调节不同器官和不同遗传背景的小鼠中鼠白细胞亚群的数量和功能的能力,并且我们评估了这种基因递送方式对确定的鼠肿瘤转移。 IL-2基因的流体动力学给药导致血清中迅速和瞬时产生高达160 ng / ml的IL-2。 IL-2的出现随后是瞬时产生的IFN-γ以及肝和脾白细胞中NK细胞数量以及NK介导的细胞溶解活性的显着和持续增加。另外,在IL-2 cDNA质粒递送后,观察到已知对IL-2有反应的其他淋巴细胞亚群(例如,NKT,T和B细胞)显着增加。最后,向携带已确定的肺和肝转移的小鼠仅4μg的IL-2质粒以流体动力学方式递送,与大量(每天100,000 IU /每天两次)给予抑制转移一样有效。在携带转移性肾细胞肿瘤的小鼠中进行的研究表明,IL-2 cDNA质粒可有效治疗肝转移,对肺转移具有中等程度的治疗作用。总的来说,这些结果表明,相对少量的IL-2 cDNA的流体动力学递送提供了一种简单而廉价的方法来增加NK和NKT细胞的数量,从而在体内诱导IL-2的生物学效应,从而与其他药物组合使用。生物制剂,并用于研究其抗肿瘤活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号